INOTUZUMAB OZOGAMICIN Pharmacologic Class Indexing
- Class set ID
- 294e7174-3b4a-4eb5-9245-3b4a769e449e
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use BESPONSA™ safely and effectively. See full prescribing information for BESPONSA. BESPONSA (inotuzumab ozogamicin) for injection, for intravenous use Initial U.S. Approval: 2017 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pharmacia & Upjohn Company LLC | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 20260206 | 8 |